Meet EPAM at BioTechX USA 2026

Join EPAM and over 1,500 life sciences professionals at this year’s BioTechX USA conference in Boston to explore how we’re driving the future of life sciences and healthcare. Focusing on ELN/LIMS modernization, lab automation, GenAI lab orchestration, lab connectivity and IoT, scientific data lakes and bioinformatics pipelines, we’re enabling improved outcomes, greater efficiency and seamless collaboration in the industry.

Stop by booth 322 to explore how our cutting-edge technologies, including our Lab of the Future, are advancing clinical trials and lab automation. Learn how real-time data capture, automation and platform interoperability help organizations make smarter decisions, accelerate discoveries and enhance patient care. 

Our experts will be on hand to discuss your challenges, share insights and explore how EPAM can help your organization move forward with the confidence and agility the industry demands. Whether you're looking to modernize your lab infrastructure or scale your clinical operations, this is where the conversation starts.

Visit us at booth 322 or book a meeting in advance to make the most of your time at the conference.

Don’t Miss Our Fireside Chat

From AI Experiments to Enterprise Impact: What Does It Really Take to Operationalize AI in Pharma

Join EPAM's Robert Fenwick and Johnson & Johnson's Justin Scheer as they explore the transformative role of AI in the pharmaceutical industry. In this discussion, they'll examine where AI is making the greatest impact, how it's reshaping key business functions and where organizations can unlock the most meaningful operational gains.

Talk Track: AI in Drug Discovery and Development
When: September 29, 2026, from 3:30 p.m. to 3:50 p.m.
Speakers:
Robert Fenwick, PhD, Innovation and Technology Consultant, EPAM
Justin Scheer, Vice President, Global Head, In Silico Discovery, Johnson & Johnson